Please login to the form below

Not currently logged in
Email:
Password:

bitopertin

This page shows the latest bitopertin news and features for those working in and with pharma, biotech and healthcare.

Abilify Maintena launches in Europe

Abilify Maintena launches in Europe

Prospects for drugs that tackle the latter remain up in the air, however; Roche's bitopertin was leading the field but generated poor results in two phase III trials reported earlier

Latest news

  • Setback for Roche as schizophrenia candidate fails studies Setback for Roche as schizophrenia candidate fails studies

    Like bitopertin both of these were being tested as add-on drugs to tackle negative symptoms, but had different mechanisms of action. ... Analysts have suggested in the past that bitopertin could achieve sales of $3bn or more if it proves effective in

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics